AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable safety profile and demonstrated promising efficacy both in combination with chemotherapy and as monotherapy...
Source
MedPage Today
Opens original article in a new tab
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
(MedPage Today) -- In a spate of recent appearances in Congress, Health Secretary Robert F. Kennedy Jr. recoiled almost every time a lawmaker referred to Medicaid cuts enacted in President Donald Trump's big 2025 tax and spending bill. Throughout...
In today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and more.
President Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White House
